LB Pharmaceuticals
PublicLB Pharmaceuticals is now publicly traded
The data on this page reflects LB Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Sep 10, 2025
Last Round
Series C
Jan 24, 2024
Total Funding Raised
$378.9M
Company Overview
LB Pharmaceuticals is a biotechnology company focused on developing innovative treatments for schizophrenia, utilizing a pro-drug approach to enhance the efficacy and safety of amisulpride for improved patient outcomes.
Sector
Biotech
AI Layer
Non-AI
Keywords
LB Pharmaceuticals Comparables
Compare LB Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eumentis Therapeutics Inc. | 70% | |
| Zhongze Therapeutics | 69% | |
| Kynexis Therapeutics | 66% |
LB Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Sep 10, 2025 | ||||
| Series C | Jan 24, 2024 | ||||
| Series B | Sep 25, 2020 | ||||
| Series A | Mar 4, 2019 | ||||
| Seed | Apr 1, 2017 |
LB Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| TCG Crossover | Series C |
| Guggenheim Securities | IPO |
| Pontifax Venture Capital | IPO |
| Vida Ventures | IPO, Series C |
| Deep Track Capital | IPO, Series C |
| TCG Crossover | IPO |
Recent news
Latest coverage and updates
- hiresSep 15, 2026
LB Pharmaceuticals, Inc. hired Susan G. Kozauer as Chief Medical Officer on Sep 15th '26.
- receives_financingJul 29, 2026
LB Pharmaceuticals, Inc. receives financing of $150M.
- receives_financingJul 29, 2026
LB Pharmaceuticals, Inc. was planning to receive financing of $150M on Jul 29th '26.
LB Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access